Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Xencor, Inc.
Atavistik Bio, Inc
Seagen Inc.
Dana-Farber Cancer Institute
Alterome Therapeutics, Inc.
BeOne Medicines
ViroMissile, Inc.
Arcus Biosciences, Inc.
Pfizer
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
BioNTech SE
Eli Lilly and Company
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
Cue Biopharma
Eli Lilly and Company
Doma Biopharmaceutical(Suzhou)Co., Ltd.
M.D. Anderson Cancer Center
Innate Pharma
Novartis
National Institutes of Health Clinical Center (CC)
MOMA Therapeutics
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Pfizer
Exelixis
Exelixis
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Toray Industries, Inc
Daiichi Sankyo
Numab Therapeutics AG
Novita Pharmaceuticals, Inc.
University of Virginia
Incyte Corporation
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Zhejiang University
Pfizer